Semaglutide
Brand names: Wegovy injection / Wegovy pill / Ozempic
Quick read · 5 min
Semaglutide (Wegovy / Ozempic) is available as a weekly injection or daily pill. In clinical trials, participants lost up to 15.2% of their body weight with the injection and up to 16.6% with the pill.
People who tend to consider this:
- ✓Want a proven GLP-1 drug with strong cardiovascular evidence
- ✓Want the choice between injection and a more affordable pill (~$149/month)
- ✓BMI 30+ or 27+ with health conditions
- ✓Prefer one of the most established weight loss medications
This may not be right if:
- ✕You have a personal or family history of medullary thyroid cancer
- ✕You have a history of pancreatitis
- ✕You are pregnant or planning to become pregnant
- ✕You want the highest weight loss available
Not a complete list. Whether this treatment is right for you depends on factors only your doctor can assess.
Pill or injection?
Semaglutide is the same drug whether injected or swallowed. The main differences are cost, convenience, and how you take it.
- ✓ Daily pill — no injection
- ✓ No refrigeration needed
- ✓ Up to 16.6% (full adherence, OASIS 4) weight loss
- ⚠ 30-min fasting window before eating
- ⚠ ≤4oz water with pill only
- ✓ Once-weekly injection
- ✓ No food timing restrictions
- ✓ Up to 15.2% weight loss
- ⚠ Needs refrigeration (36–46°F)
- ⚠ Self-injection required
Why the huge cost range? The daily pill costs ~$149/month self-pay. The weekly injection lists at ~$1,350/month but insurance often covers it. Same drug, very different price depending on how you take it.
Proven heart benefit
In the SELECT trial (17,604 participants), semaglutide reduced the risk of major heart events — heart attacks, strokes, and cardiovascular death — by 20%. It is the first and only weight loss drug to demonstrate this.
Not sure where to start? Our 2-minute quiz can help.
Take the quiz →Weight loss — what trials show
In the main injection trial (68 weeks), people lost an average of about 14.9% of their body weight — roughly 33 lbs for a 220 lb person. The pill form was studied in a separate 64-week trial, where people lost an average of 13.6% — and 16.6% among those who took every dose. A large separate study also found that semaglutide reduced the risk of major heart events by 20%.
About 1 in 10 people in trials did not respond significantly to treatment. If you have been on treatment for 12–16 weeks without meaningful weight loss, it is worth discussing this with your doctor.
These are averages from clinical trials — individual results vary. Trials compare the drug against a dummy pill, not against other weight loss drugs.
See the full trial data →How this compares
Average weight loss in clinical trials. Not a ranking — individual results vary.
Averages from clinical trials at highest approved dose. Not everyone achieves these results.
Cardiovascular & other benefits
The SELECT trial (n=17,604) demonstrated a 20% reduction in major adverse cardiovascular events (MACE — heart attack, stroke, or cardiovascular death) vs. placebo in adults with established cardiovascular disease and obesity, without diabetes. Also showed fewer heart failure events in STEP-HFpEF.
- ✓20% reduction in heart attacks and strokes (SELECT trial, established CVD)
- ✓Improved blood pressure and cholesterol across STEP trials
- ✓Reduced heart failure hospitalisations (STEP-HFpEF trial)
- ✓Improved HbA1c in people with type 2 diabetes
What to expect — week by week
Many people notice reduced hunger or feeling full sooner. This varies between people.
Most people start to see measurable weight loss during this period.
Side effects often settle around this point. Measurable weight changes are becoming more visible.
This is when most of the weight loss typically happens. Side effects usually settle.
Rate of loss slows as your body approaches equilibrium.
What is “food noise”?
Many people notice the constant background thoughts about food begin to quiet down — what researchers and patients call "food noise" starting to fade. This is one of the most commonly described early effects. Not everyone experiences this to the same degree.
Side effects
Frequencies from STEP 1. Most stomach and gut side effects are mild-to-moderate and peak during the dose increase period (first 12–16 weeks).
Percentages from STEP 1. Source: trial publication.
- •In animal studies, semaglutide caused thyroid tumours. It is unknown whether this applies to humans, but it is not prescribed to people with a personal or family history of medullary thyroid cancer.
- •Stop taking and contact your doctor immediately if you have persistent severe abdominal pain — this may be a sign of pancreatitis.
- •This drug may increase the risk of gallbladder problems, including gallstones. Tell your doctor if you develop sudden upper abdominal pain.
This is not a complete list. Your doctor can advise based on your full medical history.
Side effects are most common during the first 4–8 weeks when doses are being increased. For most people, they settle significantly after that.
Hair thinning
Some people notice hair thinning or increased shedding around months 3–6 of treatment. This is usually caused by the physical stress of rapid weight loss on the body — a temporary condition called telogen effluvium — rather than the medication itself. In most cases, hair regrows on its own within 6–12 months. If hair loss is severe or persistent, speak to your doctor.
What happens if you stop?
In STEP 4, stopping semaglutide after a 20-week run-in led to significant weight regain. In STEP 1, one-year follow-up after stopping showed participants regained approximately two-thirds of the weight they had lost.
What happens when you stop
Source: STEP-1 withdrawal study — Wilding et al. Diabetes Obes Metab 2022
medication
after stopping
after 1 year
In clinical trials, participants regained about 78% of the weight they lost within a year of stopping. This is the body returning to its defended weight — not a personal failure. Current evidence supports long-term use for people who respond well.
Muscle and lean mass
DXA substudy data from STEP 1 showed semaglutide led to proportionally greater reduction in fat mass than lean mass — consistent with findings from other GLP-1 drugs. Lean mass loss was proportional to the amount of weight lost overall.
What does the lost weight consist of?
Resistance training (weight lifting, bodyweight exercises) can significantly reduce the lean mass portion. Aim for 2–3 sessions per week during weight loss.
Source: STEP-1 body composition analysis (DEXA scan)
Resistance training and high-protein intake are the two most evidence-based ways to protect lean mass during medicated weight loss.
Cost & access
Pill: ~$149/month self-pay (~$25 with insurance). Injection: ~$1,350/month list price. Novo Nordisk NovoCare programme available.
Requires a prescription from a licensed healthcare provider. Prices vary. Ask your doctor about savings programs.
~$149–$1350/moper month (list price)
Pill form (Wegovy 25mg): ~$149/month self-pay. Injection form (Wegovy 2.4mg): ~$1,350/month list. NovoCare assistance available.
Common questions
How does semaglutide work? It mimics a natural hormone (GLP-1) that tells your brain you're full, slows digestion, and reduces appetite.
Read the full explanation: How GLP-1 drugs work →Community insights
These are personal experiences shared in public online communities — not medical advice.
“Sulfur burps are common early on — ginger tea, smaller meals, and avoiding carbonated drinks help the most. They usually fade after the first few months.”
“Protein first at every meal — aim for 60–80g/day minimum. It helps preserve muscle, keeps hunger controlled between doses, and reduces nausea.”
“The week 12–16 plateau is real. Many people stall for 2–3 weeks and almost quit, then the scale starts moving again. Stay consistent.”
“Rotate injection sites — thigh, abdomen, upper arm. Using the same spot repeatedly can cause hard lumps under the skin. Switching fixed it for most people.”
Common patterns people report
From public online communities — not medical evidence.
- •Appetite changes most noticeable in first 2–4 weeks
- •Nausea peaks during dose escalation (weeks 1–8), then settles
- •Weight loss plateaus around week 12–16 are commonly reported — a distinctive timing pattern with semaglutide
- •Food noise quieting commonly reported in early weeks
How people tend to think about this option
- —This drug has proven cardiovascular benefit — the first weight loss drug to reduce heart attacks and strokes in a large trial.
- —Pill form at ~$149/month makes it dramatically more affordable than injection options.
- —Weight loss is moderate compared to tirzepatide but solid and well-documented.
- —Requires ongoing use — weight regain is expected after stopping.
These are common considerations — not recommendations. Your doctor can help assess which factors matter most for your situation.
Deep dives
Dedicated pages on how to take it, dosage, side effects, and cost.
Week-by-week experience, the 12-month journey arc, and practical tips for starting
Full step-by-step guide, storage, missed doses
Available doses, dose-response, maintenance
Step-up timeline from starting dose to maintenance
Full list with frequencies, warnings, and management
Contraindications, cautions, and drug interactions
List prices, savings programs, insurance reality
Month-by-month results at 1, 3, 6, and 12 months in real pounds
Fridge rules, room temp window, travel, damaged pens
Alcohol, metformin, thyroid, BP drugs, NSAIDs, and more
Protein targets, meal ideas, and the eating-too-little trap
The 5-day window and when to skip
Where to inject, rotation schedule, and troubleshooting lumps
Why two brand names exist and what the FDA approval difference means for insurance
Related comparisons
After reading this page, most people compare this with other medications, check if they qualify, or learn about side effects in more detail.
Next step most people take
Based on clinical trials · No rankings · Every claim linked to source
Last reviewed: April 2026